Data Insights
                                    By  Company Name
                                
                                No Filter Selected
                                    By  Disease Name
                                
                                No Filter Selected
                                    By  Drug Name
                                
                                No Filter Selected
                                    By Themes
                                
                                No Filter Selected
                                    Showing 2 results out of 2                                
                                
                                                Data Insights
                                                
                                        Danicopan by Alexion Pharmaceuticals for Coronavirus Disease 2019 (COVID-19): Likelihood of Approval
Danicopan is under clinical development by Alexion Pharmaceuticals and currently in Phase II for Coronavirus Disease 2019 (COVID-19). According to...
                                                Data Insights
                                                
                                        Danicopan by Alexion Pharmaceuticals for Atypical Hemolytic Uremic Syndrome (Nondiarrhea - Associated Hemolytic Uremic Syndrome): Likelihood of Approval
Danicopan is under clinical development by Alexion Pharmaceuticals and currently in Phase I for Atypical Hemolytic Uremic Syndrome (Nondiarrhea -...
